Advances in Precision Medicine Highlight SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

5. Drug for Rare Form of Rickets Gets FDA Approval

Burosumab (Crysvita, Ultragenyx) is the first treatment approved for x-linked hypophosphatemia in adults and children ages 1 and older.

Click to read more.

4. Study Sheds Light on How HIV Evades the Immune System

HIV targets and disables a pathway involved in blocking viral activity and clearing infection.

Click to read more.

3. High Carbohydrate Diet May Increase Mortality Risk in Certain Cancers

The findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.

Click to read more.

2. Breakthrough Technique Improves Precision of Gene-Editing Technology

A synthetic bridged nucleic acid was found to greatly improve the accuracy of gene-editing technology, which could potentially lead to new therapies for genetic diseases.

Click to read more.

1. New Technology Could Advance Precision Medicine for Cancer, Neurological Disorders

The new method indexes thousands of cells simultaneously and could potentially improve understanding of various diseases at a molecular level.

Click to read more.